###begin article-title 0
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 24 41 24 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 45 67 45 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 24 40 <span type="species:ncbi:562">Escherichia coli</span>
###xml 45 66 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 24 43 24 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterobacteriaceae </italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 430 449 430 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterobacteriaceae </italic>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 811 819 811 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 823 837 823 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
###xml 663 671 <span type="species:ncbi:9606">children</span>
###xml 811 818 <span type="species:ncbi:562">E. coli</span>
###xml 823 836 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 852 860 <span type="species:ncbi:9606">patients</span>
Quinolone resistance in Enterobacteriaceae results mainly from mutations in type II DNA topoisomerase genes and/or changes in the expression of outer membrane and efflux pumps. Several recent studies have indicated that plasmid-mediated resistance mechanisms also play a significant role in fluoroquinolone resistance, and its prevalence is increasing worldwide. In China, the presence of the qnr gene in the clinical isolates of Enterobacteriaceae has been reported, but this transmissible quinolone resistance gene has not been detected in strains isolated singly from pediatric patients. Because quinolones associated with a variety of adverse side effects on children, they are not authorized for pediatric use. This study therefore aimed to investigate the presence of the qnr gene in clinical isolates of E. coli and K. pneumoniae from pediatric patients in China.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 92 106 92 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA</italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB</italic>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
###xml 411 419 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr</italic>
###xml 80 87 <span type="species:ncbi:562">E. coli</span>
###xml 92 105 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 156 164 <span type="species:ncbi:9606">children</span>
###xml 411 418 <span type="species:ncbi:562">E. coli</span>
A total 213 of non-repetitive clinical isolates resistant to ciprofloxacin from E. coli and K. pneumoniae were collected from hospitalized patients at five children's hospital in Beijing, Shanghai, Guangzhou, and Chongqing. The isolates were screened for the plasmid-mediated quinolone resistance genes of qnrA, qnrB, and qnrS by PCR. Transferability was examined by conjugation with the sodium azide-resistant E. coli J53. All qnr-positive were analyzed for clonality by enterobacterial repetitive intergenic consensus (ERIC)-PCR.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 81 95 81 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 69 76 <span type="species:ncbi:562">E. coli</span>
###xml 81 94 <span type="species:ncbi:573">K. pneumoniae</span>
The study found that 19 ciprofloxacin-resistant clinical isolates of E. coli and K. pneumoniae were positive for the qnr gene, and most of the qnr positive strains were ESBL producers. Conjugation experiments showed that quinolone resitance could be transferred to recipients. Apart from this, different DNA banding patterns were obtained by ERIC-PCR from positive strains, which means that most of them were not clonally related.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 93 107 93 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 81 88 <span type="species:ncbi:562">E. coli</span>
###xml 93 106 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
This report on transferable fluoroquinolone resistance due to the qnr gene among E. coli and K. pneumoniae strains indicated that plasmid-mediated quinolone resistance has emerged in pediatric patients in China.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 24 43 24 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterobacteriaceae </italic>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA </italic>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB </italic>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS</italic>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 679 683 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 712 731 712 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterobacteriaceae </italic>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 759 760 759 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1106 1110 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 1163 1180 1163 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 1184 1206 1184 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 894 902 <span type="species:ncbi:9606">patients</span>
###xml 976 984 <span type="species:ncbi:9606">children</span>
###xml 1163 1179 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1184 1205 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 1221 1229 <span type="species:ncbi:9606">patients</span>
Quinolone resistance in Enterobacteriaceae results mainly from mutations in type II DNA topoisomerase genes[1] and/or changes in the expression of outer membrane and efflux pumps[2]. Recently, studies have shown that plasmid-mediated resistance mechanisms also play a significant role in fluoroquinolone resistance, and its prevalence is increasing worldwide [3]. qnrA is the plasmid-mediated quinolone resistance gene encoding a 218 amino acid protein of the pentapeptide family that protects DNA gyrase from quinolone inhibition[4]. The new plasmid-mediated quinolone resistance genes, qnrB and qnrS, have been reported in clinical isolates[5,6]. In China, the presence of the qnr gene in clinical isolates of Enterobacteriaceae from Shanghai [7] and Anhui[8] has been reported, but this transmissible quinolone resistance gene has not been detected in strains isolated singly from pediatric patients. Because quinolones associated with a variety of adverse side effects on children, they are not authorized for pediatric use. Therefore, the objective of this study was to screen for the presence of the qnr gene in clinical ciprofloxacin-resistant isolates of Escherichia coli and Klebsiella pneumoniae from pediatric patients in China.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Bacterial strains
###end title 13
###begin p 14
###xml 26 43 26 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 51 73 51 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 642 659 642 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 666 688 666 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 754 762 754 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 767 768 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R</sup>
###xml 26 42 <span type="species:ncbi:562">Escherichia coli</span>
###xml 51 72 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 130 138 <span type="species:ncbi:9606">children</span>
###xml 464 472 <span type="species:ncbi:9606">Children</span>
###xml 642 658 <span type="species:ncbi:562">Escherichia coli</span>
###xml 666 687 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 754 761 <span type="species:ncbi:562">E. coli</span>
Three hundred thirty-five Escherichia coli and 392 Klebsiella pneumoniae non-replicate clinical isolates were collected from five children's hospitals located in Beijing, Shanghai, Guangzhou, and Chongqing from January 2005 to December 2006. Each hospital is a general pediatric hospital locally affiliated to a university. The isolates were identified at the participating hospitals by routine methodology at each laboratory, and then were transported to Beijing Children's Hospital for further analysis. All isolates were screened for ciprofloxacin resistance by disk method according to the criteria of NCCLS [9]. The screening showed 146 Escherichia coli and 67 Klebsiella pneumoniae isolates were ciprofloxacin-resistant. Additional strain used was E. coli J53AzR(resistant to azide) as a recipient of the conjugation experiment
###end p 14
###begin title 15
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrAM</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
Screening for the qnrAM, qnrB, and qnrS gene in clinical strains
###end title 15
###begin p 16
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 55 69 55 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 117 127 117 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA, qnrB</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 298 319 298 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA, qnrB, and qnrS </italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA </italic>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB </italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB </italic>
###xml 948 958 930 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA, qnrB</italic>
###xml 964 969 946 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
###xml 43 50 <span type="species:ncbi:562">E. coli</span>
###xml 55 68 <span type="species:ncbi:573">K. pneumoniae</span>
The 213 ciprofloxacin-resistant strains of E. coli and K. pneumoniae were screened by multiplex PCR amplification of qnrA, qnrB, and qnrS as previously described[10]. Colonies were transferred to an Eppendorf tube filled with water and boiled to prepare DNA templates for PCR. The primers used for qnrA, qnrB, and qnrS were as follows: '5-ATTTCTCACGCCAGGATTTG-3' and 5'-GATCGGCAAAGGTTAGGTCA-3' for qnrA for a 516-bp product, 5'-GATCGTGAAAGCCAGAAAGG-3' and 5'-ACGATGCCTGGTAGTTGTCC-3' for qnrB for a 469-bp product, and 5'-ACGACATTCGTCAACTGCAA-3' and 5'-TAAATTGGCACCCTGTAGGC-3' for qnrB for a 417-bp product. The protocol for the PCR condition was: 94degreesC for 45 s, 53degreesC for 45 s, and 72degreesC for 60 s, with a cycle number of 32, and without DNA template as negative controls in each run. Amplification products were provisionally identified by their size in ethidium bromide-stained agarose gels. The positive amplified PCR product for qnrA, qnrB, and qnrS was analyzed with an automated DNA sequencing system. The results of DNA sequences were compared with the BLAST online search engine from GenBank at the National Center for Biotechnology Information Web site: .
###end p 16
###begin title 17
Conjugation experiments
###end title 17
###begin p 18
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 133 141 133 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 146 148 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 825 829 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 133 140 <span type="species:ncbi:562">E. coli</span>
All positive qnr strains were tested for transferred quinolone resistance by conjugation experiments carried out in Luria Broth with E. coli J53AzR as the recipient. The cultures of donor and recipient cells were incubated via shaking at 37degreesC in logarithmic phase, and then 0.5 mL of both cultures was added to 4 mL of fresh LB and incubated overnight without shaking. Transconjugants were selected on trypticase soy agar (TSA) plates with sodium azide (100 mug/mL from Sigma Chemical Co., St. Louis, MO) for counter selection and ampicillin (100 mug/mL from Oxoid) to select for plasmid-encoded resistance. To determine if quinolone resistance was cotransferred, colonies were replica-plated onto TSA with and without ciprofloxacin (0.06 mug/mL; Oxoid). The PCR experiments confirmed transconjugants carrying the same qnr gene as their donors.
###end p 18
###begin title 19
Antimicrobial susceptibility profiles
###end title 19
###begin p 20
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R</sup>
###xml 416 433 416 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 416 432 <span type="species:ncbi:562">Escherichia coli</span>
MICs for the 19 positive qnr isolates, recipient (J53 AzR), and transconjugant strains were measured by agar dilution in accordance with the guidelines of the NCCLS. The antimicrobials tested were ampicillin/clavulanic acid, cefotaxime, ceftazidime, cefoperazone, cefoxitin, cefepime, aztreonam, imipenem, ciprofloxacin, ofloxacin, amikacin, and gentamicin (Oxoid, England). Quality control was performed by testing Escherichia coli ATCC25922. Isolates which showed MICs >/= 2 mug/ml for cefotaxime and/or ceftriaxone and/or ceftazidime and/or aztreonam were considered as ESBL producers. The ESBL phenotype was confirmed by using clavulanic acid (Oxoid, England) according to the manufacturer's recommendation.
###end p 20
###begin title 21
Strain typing by ERIC-PCR
###end title 21
###begin p 22
###xml 16 37 16 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr Escherichia coli </italic>
###xml 60 86 60 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr Klebsiella pneumoniae </italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 206 234 206 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5'-ATGTAAGCTCCTGGGGATTCAC-3'</italic>
###xml 247 275 247 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5'-AAGTAAGTGACTGGGGTGAGCG-3'</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 818 820 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 20 36 <span type="species:ncbi:562">Escherichia coli</span>
###xml 64 85 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
The 11 positive qnr Escherichia coli strains and 8 positive qnr Klebsiella pneumoniae strains were typed by ERIC-PCR. Total DNA from qnr positive isolates was analyzed by ERIC sequence PCR with the ERIC1R (5'-ATGTAAGCTCCTGGGGATTCAC-3') and ERIC2 (5'-AAGTAAGTGACTGGGGTGAGCG-3') primers, and PCR was performed as previously described [11]. ERIC-PCR was performed briefly using the following program parameters: denaturation at 94degreesC for 1 s, annealing at 52degreesC for 10 s, and extension at 72degreesC for 35 s for 30 cycles, followed by a final extension at 72degreesC for 4 min. Amplicons were separated on a 1.5% agarose gel containing ethidium bromide (5 mug/mL) at 60 V for 3 hours. The gels were photographed and digitized. Isolates were considered different if their profiles differed by two or more bands[12].
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
Screening for the qnr genes
###end title 24
###begin p 25
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 87 101 87 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA</italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB</italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA </italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB </italic>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
###xml 69 76 <span type="species:ncbi:562">E. coli</span>
###xml 87 100 <span type="species:ncbi:573">K. pneumoniae</span>
Nineteen ciprofloxacin-resistant clinical isolates, including eleven E. coli and eight K. pneumoniae strains, were positive for the qnr gene. Table 1 shows the clinical characteristics of these isolates and the distribution of qnrA, qnrB, or qnrS. The sequences of qnr genes were all identical to those of qnrA (EU195836), qnrB (EU443840), and qnrS (EU391634) with GenBank, respectively.
###end p 25
###begin p 26
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr</italic>
Clinical characteristics and qnr genotype of the qnr-positive isolates
###end p 26
###begin p 27
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aUTI, Urinary tract infection;
###end p 27
###begin p 28
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bALL, Acute lymphoblastic leukemia.
###end p 28
###begin title 29
Conjugation and antimicrobial susceptibility
###end title 29
###begin p 30
###xml 76 101 76 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae qnr</italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS</italic>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 326 329 326 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr</italic>
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 564 581 564 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 620 642 620 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 76 97 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 564 580 <span type="species:ncbi:562">Escherichia coli</span>
###xml 620 641 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Quinolone resistance could be transferred by conjugation in two of eight of Klebsiella pneumoniae qnr-positive donors. One qnrB-positive and one qnrS-positive transconjugant were obtained. PCR experiments confirmed that the transconjugants harbored the same qnr gene as their donors. Table 2 shows the susceptibilities of the qnr-positive clinical isolates for the selected antibiotics. Most isolates were resistant to cephalosporin, aztreonam, and aminoglycosides, whereas all of the strains were susceptible to imipenem. Eight of eleven qnr positive isolates of Escherichia coli and all eight qnr positive isolates of Klebsiella pneumoniae were phenotypic ESBL producers, respectively. Antibiotic susceptibilities for the two transconjugants showed that the ciprofloxacin resistance MIC value increased 32- and 1024-fold, respectively; meanwhile, oflaxacin resistance MIC value increased 2- and 32-fold, respectively.
###end p 30
###begin p 31
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
Resistance profiles of the qnr positive strains and transconjugants
###end p 31
###begin p 32
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a AMC, amoxicillin/clavulanic acid; CFP, cefoperazone; CTX, cefotaxime; CAZ, cefotaxime; FOX, cefoxitin; FEP, cefepime; IPM/CS, imipenem/cilastatin; ATM, aztreonam; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; OFX, ofloxacin.
###end p 32
###begin p 33
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
b domor;
###end p 33
###begin p 34
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
c Tc, transconjugants
###end p 34
###begin title 35
Strain typing by ERIC-PCR
###end title 35
###begin p 36
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 42 56 42 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 29 36 <span type="species:ncbi:562">E. coli</span>
###xml 42 55 <span type="species:ncbi:573">K. pneumoniae</span>
The positive qnr isolates of E. coli, and K. pneumoniae showed different DNA banding patterns, indicating that they were not clonally related.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 188 196 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 289 306 289 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 466 474 466 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA </italic>
###xml 610 623 610 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterobacter </italic>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA </italic>
###xml 712 729 712 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrB </italic>
###xml 786 808 786 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 188 195 <span type="species:ncbi:562">E. coli</span>
###xml 289 305 <span type="species:ncbi:562">Escherichia coli</span>
###xml 466 473 <span type="species:ncbi:562">E. coli</span>
###xml 712 728 <span type="species:ncbi:562">Escherichia coli</span>
###xml 786 807 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
This study is the first report on the presence of the qnr gene in clinical isolates from pediatric patients in China. The prevalence rates of qnr among ciprofloxacin-resistant isolates of E. coli and K. were 7.5% (11 of 146), and 11.9% (8 of 67), respectively. The qnr rate in isolates of Escherichia coli analyzed in this study was similar to the prevalence in Shanghai, China, wherein there was 8% (6 of 78 strains) of ciprofloxacin-resistant clinical isolates of E. coli [7]. These rates are lower than the prevalence of qnrA detected among ceftazidime-resistant or ciprofloxacin-resistant strains (24%) of Enterobacter in USA[13]. Among the three groups of the qnr gene, qnrA was more prevalent (8 of 11) in Escherichia coli strains, whereas qnrB was more prevalent (5 of 8) in the Klebsiella pneumoniae isolates. As there are differences in the criteria for testing strains, evaluating the precise prevalence of plasmid-mediated quinolone resistance was difficult.
###end p 38
###begin p 39
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 754 770 754 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shewanella algae</italic>
###xml 794 799 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA </italic>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 815 833 815 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio splendidus </italic>
###xml 836 849 836 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aeromonas spp</italic>
###xml 870 875 870 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1337 1342 1337 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
###xml 1369 1377 1369 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1381 1392 1381 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. cloacae </italic>
###xml 1515 1517 1515 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1642 1644 1642 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1693 1697 1693 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 133 141 <span type="species:ncbi:9606">children</span>
###xml 287 295 <span type="species:ncbi:9606">children</span>
###xml 338 346 <span type="species:ncbi:9606">children</span>
###xml 385 393 <span type="species:ncbi:9606">children</span>
###xml 754 770 <span type="species:ncbi:38313">Shewanella algae</span>
###xml 815 832 <span type="species:ncbi:29497">Vibrio splendidus</span>
###xml 1369 1376 <span type="species:ncbi:562">E. coli</span>
###xml 1381 1391 <span type="species:ncbi:550">E. cloacae</span>
###xml 1781 1789 <span type="species:ncbi:9606">children</span>
It should be noted that all the positive qnr isolates were distributed in pediatric patients: more than one-third were isolated from children younger than one year of age, and nearly one-fourth were isolated from neonates. Because of the variety of adverse side effects of quinolones in children, hospitals are not advised to use them on children. In China, quinolones are not used on children younger than 16 years old. Presumably, the source of the qnr gene might not be directly associated with the selective pressure caused by the quinolones used in pediatrics, but it could be related to horizontal transmission from adults or other reservoir. Recent findings showed that these genes come from environmental gram-negative bacterial species, such as Shewanella algae, the progenitor of the qnrA genes [14], and Vibrio splendidus or Aeromonas spp., the progenitor of qnrS genes[15,16]. This shows that the aquatic environment is an important reservoir of novel antibiotic resistance determinants. Quinolones are antimicrobial agents extensively used in aquaculture and are stable molecules in water [17]. Exposure to lower concentrations of quinolones increases the chance for seletion of resistance. Therefore, they may be the source of an important driving force for the selection of quinolone resistance. Another study showed that qnrS genes were identified from E. coli and E. cloacae isolated from zoo animals in Japan, suggesting that animals could be a potential reservoir of quinolone-resistant bacteria[18]. Quinolones are the most common antimicrobial used in animals, the annual consumption of which is about 470 tons in China [19]. In the present study, more than two-thirds of qnr positive strains were isolated from sputum sample. These strains may be confined in children's respiratory tract, which come from the contaminated environment.
###end p 39
###begin p 40
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrA</italic>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnrS </italic>
###xml 258 272 258 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 258 271 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 413 421 <span type="species:ncbi:9606">children</span>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
This study showed that most qnr positive strains were ESBL producers, indicating the relationship between the qnr gene and ESBL. Other studies have shown that several qnrA-positive isolates express ESBL [7,20,21]. A qnrS gene on a plasmid encoding ESBL in a K. pneumoniae strain also has been reported in Taiwan, China [22]. Therefore, the fact that expanded-spectrum cephalosporins are widely used among Chinese children may also contribute to the presence of the qnr gene. Another study by the present researchers suggested that third-generation cephalosporins are commonly used in pediatric patients (data not published).
###end p 40
###begin p 41
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr</italic>
###xml 58 72 58 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 233 236 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 58 71 <span type="species:ncbi:573">K. pneumoniae</span>
Conjugation experiments showed that only two qnr-positive K. pneumoniae strains were able to transfer the qnr gene in transconjugants. This transferability was similar to the findings of other studies, which also showed that not all qnr-positive strains were able to transfer quinolone resistance [23,24]. The lower resistance to ciprofloxacin and oflaxacin in these two transconjugants than their donor strains may imply the presence of additional chromosomal resistance mutations. The results of ERIC-PCR showed that the positive qnr strains have different types of DNA band, thereby suggesting that the qnr in clinical isolates was not caused by the spread of identical strains.
###end p 41
###begin p 42
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 148 162 148 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 136 143 <span type="species:ncbi:562">E. coli</span>
###xml 148 161 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
###xml 326 334 <span type="species:ncbi:9606">patients</span>
Although the number of data points is limited, this report confirms the spread of the plasmid-mediated quinolone resistance qnr gene in E. coli and K. pneumoniae strains isolated from pediatric patients. Still, however, further research is needed to understand the influence of this gene on quinolone resistance for pediatric patients in China.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 99 113 99 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qnr </italic>
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 262 276 262 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 87 94 <span type="species:ncbi:562">E. coli</span>
###xml 99 112 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 250 257 <span type="species:ncbi:562">E. coli</span>
###xml 262 275 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
The prevalence rates of qnr among the clinical isolates of ciprofloxacin resistance in E. coli and K. pneumoniae were 7.5% (11 of 146) and 11.9% (8 of 67), respectively. The transferability of fluoroquinolone resistance because of the qnr gene among E. coli and K. pneumoniae strains shows that plasmid-mediated quinolone resistance has been spread in pediatric patients in China.
###end p 44
###begin title 45
Competing interests
###end title 45
###begin p 46
The authors declare that they have no competing interests.
###end p 46
###begin title 47
Authors' contributions
###end title 47
###begin p 48
###xml 590 598 <span type="species:ncbi:9606">patients</span>
All authors of the present study contributed substantially to the conception and design of the study, were involved in the writing and in the critical revision of the manuscript, and read and approved the final version of the manuscript submitted for publication. AW was mainly responsible for data analysis and preparation of the manuscript; XS and YY conceived of the study, participated in its design and coordination, and helped in drafting the manuscript; QL, YW, YC, LD, QD, HZ, CW, LL, and XX were mainly responsible for the collection of clinical isolates and information about the patients; and HD and LW facilitated the PCR and conjugation experiments on the samples.
###end p 48
###begin title 49
Pre-publication history
###end title 49
###begin p 50
The pre-publication history for this paper can be accessed here:
###end p 50
###begin p 51

###end p 51
###begin title 52
Acknowledgements
###end title 52
###begin p 53
This study was sponsored by the Health Ministry of China (No. 2004BA720A09-01). The authors are greatly thankful to all the hospitals for their support and participation in the research; and Minggui Wang, Huashan Hospital of Fudan University, for his kindly help in the preparation of this paper.
###end p 53
###begin article-title 54
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae
###end article-title 54
###begin article-title 55
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
###end article-title 55
###begin article-title 56
The worldwide emergence of plasmid-mediated quinolone resistance
###end article-title 56
###begin article-title 57
###xml 73 89 <span type="species:ncbi:562">Escherichia coli</span>
Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase
###end article-title 57
###begin article-title 58
qnrB, another plasmid-mediated gene for quinolone resistance
###end article-title 58
###begin article-title 59
###xml 113 133 <span type="species:ncbi:550">Enterobacter cloacae</span>
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital
###end article-title 59
###begin article-title 60
###xml 62 78 <span type="species:ncbi:562">Escherichia coli</span>
Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China
###end article-title 60
###begin article-title 61
###xml 80 100 <span type="species:ncbi:550">Enterobacter cloacae</span>
Emerging plasmid-mediated quinolone resistance associated with the qnrA gene in Enterobacter cloacae clinical isolates in China
###end article-title 61
###begin article-title 62
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States
###end article-title 62
###begin article-title 63
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
###xml 115 123 <span type="species:ncbi:9031">chickens</span>
Impact of antimicrobial usage on antimicrobial resistance in commensal Escherichia coli strains colonizing broiler chickens
###end article-title 63
###begin article-title 64
###xml 55 78 <span type="species:ncbi:670">Vibrio parahaemolyticus</span>
Characterization of United States outbreak isolates of Vibrio parahaemolyticus using enterobacterial repetitive intergenic consensus (ERIC) PCR and development of a rapid PCR method for detection of O3:K6 isolates
###end article-title 64
###begin article-title 65
Broader distribution of plasmid-mediated quinolone resistance in the United States
###end article-title 65
###begin article-title 66
Origin of plasmid-mediated quinolone resistance determinant QnrA
###end article-title 66
###begin article-title 67
###xml 0 17 <span type="species:ncbi:29497">Vibrio splendidus</span>
Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants
###end article-title 67
###begin article-title 68
Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp
###end article-title 68
###begin article-title 69
Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital
###end article-title 69
###begin article-title 70
Zoo animals as reservoirs of gram-negative bacteria harboring integrons and antimicrobial resistance genes
###end article-title 70
###begin article-title 71
###xml 58 63 <span type="species:ncbi:9606">human</span>
Use of quinolones in food animals and potential impact on human health. WHO/EMC/IDI/98.10
###end article-title 71
###begin article-title 72
###xml 101 107 <span type="species:ncbi:9103">Turkey</span>
Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey
###end article-title 72
###begin article-title 73
Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1
###end article-title 73
###begin article-title 74
###xml 153 174 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate
###end article-title 74
###begin article-title 75
Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units
###end article-title 75
###begin article-title 76
###xml 41 57 <span type="species:ncbi:562">Escherichia coli</span>
Detection of qnr in clinical isolates of Escherichia coli from Korea
###end article-title 76

